3-Methyl-N-{4-[4-(propan-2-yl)piperazin-1-yl]phenyl}benzamide

Catalog No.: 
ACOZGL477
CAS No.: 
478065-80-4
Molecular Formula: 
C21H27N3O
Molecular Weight: 
337.47
3-Methyl-N-{4-[4-(propan-2-yl)piperazin-1-yl]phenyl}benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$109.00InquiryInquiry
1g90%$322.00InquiryInquiry
5g90%$1594.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-N-{4-[4-(propan-2-yl)piperazin-1-yl]phenyl}benzamide
IUPAC NameN-(4-(4-isopropylpiperazin-1-yl)phenyl)-3-methylbenzamide
MDL No.MFCD02187479
Molecular FormulaC21H27N3O
Molecular Weight337.47
SMILESO=C(NC1=CC=C(N2CCN(C(C)C)CC2)C=C1)C3=CC=CC(C)=C3
InChI KeyWZKJLERPHRCVNX-UHFFFAOYSA-N
SynonymN-[4-(4-ISOPROPYLPIPERAZINO)PHENYL]-3-METHYLBENZENECARBOXAMIDE;3-methyl-N-{4-[4-(propan-2-yl)piperazin-1-yl]phenyl}benzamide;Benzamide, 3-methyl-N-[4-[4-(1-methylethyl)-1-piperazinyl]phenyl]-
CAS No.478065-80-4

Synthetic Route by SureRoute

1. ACOZGL477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBJTY052 route compound structure diagram
    ACBJTY05299-04-7In Stock
  4. Then
  5. ACOZGL477 route product structure diagram
    ACOZGL477478065-80-4
Inquiry

2. ACOZGL477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZGL477 route product structure diagram
    ACOZGL477478065-80-4
Inquiry

3. ACOZGL477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZGL477 route product structure diagram
    ACOZGL477478065-80-4
Inquiry

Comments (0)